Phase 2 Study
Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| bexobrutideg | Nurix Therapeutics, Inc. (NRIX) |
Phase 2(1)
| Drug | Company |
|---|---|
| Evalstotug (BA3071) | BioAtla, Inc. (BCAB) |
Compare drugs
Frequently asked questions
How many drugs are in development for Phase 2 Study?
BioSniper tracks 2 drugs in development for Phase 2 Study across 2 companies.
How many clinical trials target Phase 2 Study?
There are 2 clinical trials targeting Phase 2 Study tracked by BioSniper.
Deep-dive into Phase 2 Study
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis